Literature DB >> 11564651

Inhibitory action of nociceptin/orphanin FQ on functionally different thalamic neurons in urethane-anaesthetized rats.

D Albrecht1, R Blühdorn, H Siegmund, H Berger, G Calo'.   

Abstract

1. In this study we administered nociceptin/orphanin FQ (NC) ionotophoretically onto neurons located in functionally distinct thalamic structures of urethane-anesthetized rats. Extracellular single unit recordings were made in the medial and lateral ventroposterior nucleus, posterior thalamic nucleus, zona incerta, lateral posterior nucleus, laterodorsal nucleus, ventrolateral nucleus and reticular nucleus. 2. NC decreased the firing rate in 60% of thalamic neurons. This decrease in firing rate was accompanied by a significant reduction in the number of high threshold bursts. 3. In about 20% of the neurons NC increased the firing rate. In most cells NC-induced increases in discharge rate could be blocked by the GABA(A) receptor antagonists bicuculline and SR 95531. 4. The NC receptor ligands [Phe(1)Psi(CH(2)-NH)Gly(2)] nociceptin(1-13)NH(2), Ac-RYYRIK-NH(2) and [Nphe(1)]NC(1-13)NH(2) were also evaluated. All these peptides inhibited NC-induced changes in firing rate. In addition, in some neurons where NC inhibited firing, [Nphe(1)]NC(1-13)NH(2) and Ac-RYYRIK-NH(2) elicited per se an increase in firing rate, suggesting the existence of tonic innervation of thalamic neurons by NC-containing fibres. 5. In NC-inhibited neurons nocistatin induced a significant increase in firing rate. 6. The present study demonstrated that NC regulates various thalamic nuclei related not only to somatosensory, but also to the visual and motor functions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11564651      PMCID: PMC1572959          DOI: 10.1038/sj.bjp.0704264

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  49 in total

1.  Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-[(3R,4R)-1-cyclooctylmethyl-3- hydroxymethyl-4-piperidyl]-3-ethyl-1, 3-dihydro-2H-benzimidazol-2-one (J-113397).

Authors:  H Kawamoto; S Ozaki; Y Itoh; M Miyaji; S Arai; H Nakashima; T Kato; H Ohta; Y Iwasawa
Journal:  J Med Chem       Date:  1999-12-16       Impact factor: 7.446

Review 2.  Pharmacology of nociceptin and its receptor: a novel therapeutic target.

Authors:  G Calo'; R Guerrini; A Rizzi; S Salvadori; D Regoli
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

3.  Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat.

Authors:  C R Neal; A Mansour; R Reinscheid; H P Nothacker; O Civelli; S J Watson
Journal:  J Comp Neurol       Date:  1999-04-19       Impact factor: 3.215

4.  Nociceptin, Phe(1)psi-nociceptin(1 - 13), nocistatin and prepronociceptin(154 - 181) effects on calcium channel currents and a potassium current in rat locus coeruleus in vitro.

Authors:  M Connor; C W Vaughan; E A Jennings; R G Allen; M J Christie
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

5.  [Phe1psi(CH2-NH)Gly2]nociceptin-(1 - 13)-NH2 activation of an inward rectifier as a partial agonist of ORL1 receptors in rat periaqueductal gray.

Authors:  L C Chiou
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

6.  Antagonism by acetyl-RYYRIK-NH2 of G protein activation in rat brain preparations and of chronotropic effect on rat cardiomyocytes evoked by nociceptin/orphanin FQ.

Authors:  H Berger; E Albrecht; G Wallukat; M Bienert
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

7.  Effect of nociceptin and [Phe1psi (CH2-NH) Gly2]-nociceptin-(1-13)-NH2 on tonic activity of rat hypothalamic neurons.

Authors:  K S Yakimova; F K Pierau
Journal:  Neurosci Lett       Date:  1999-10-22       Impact factor: 3.046

8.  Characterization of [Nphe(1)]nociceptin(1-13)NH(2), a new selective nociceptin receptor antagonist.

Authors:  G Calo'; R Guerrini; R Bigoni; A Rizzi; G Marzola; H Okawa; C Bianchi; D G Lambert; S Salvadori; D Regoli
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

9.  Selective suppression of inhibitory synaptic transmission by nocistatin in the rat spinal cord dorsal horn.

Authors:  H U Zeilhofer; U M Selbach; H Guhring; K Erb; S Ahmadi
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

10.  Nociceptin augments K(+) currents in hippocampal CA1 neurons by both ORL-1 and opiate receptor mechanisms.

Authors:  S G Madamba; P Schweitzer; G R Siggins
Journal:  J Neurophysiol       Date:  1999-10       Impact factor: 2.714

View more
  9 in total

Review 1.  Functional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists.

Authors:  W Schröder; D G Lambert; M C Ko; T Koch
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

2.  Nocistatin and nociceptin modulate c-Fos expression in the mice thalamus.

Authors:  Jamil Ahsan Kazi
Journal:  Neurol Sci       Date:  2012-01-13       Impact factor: 3.307

3.  Nociceptin/orphanin FQ presynaptically decreases GABAergic transmission and blocks the ethanol-induced increase of GABA release in central amygdala.

Authors:  Marisa Roberto; George R Siggins
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-20       Impact factor: 11.205

4.  Direct and indirect inhibition by nociceptin/orphanin FQ on noradrenaline release from rodent cerebral cortex in vitro.

Authors:  Anna Siniscalchi; Donata Rodi; Michele Morari; Matteo Marti; Sabrina Cavallini; Silvia Marino; Lorenzo Beani; Clementina Bianchi
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

5.  Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior.

Authors:  Matteo Marti; Flora Mela; Carlo Veronesi; Remo Guerrini; Severo Salvadori; Mauro Federici; Nicola B Mercuri; Anna Rizzi; Gianfranco Franchi; Lorenzo Beani; Clementina Bianchi; Michele Morari
Journal:  J Neurosci       Date:  2004-07-28       Impact factor: 6.167

6.  Nocistatin inhibits 5-hydroxytryptamine release in the mouse neocortex via presynaptic Gi/o protein linked pathways.

Authors:  M Fantin; C Fischetti; C Trapella; M Morari
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

7.  Central injections of nocistatin or its C-terminal hexapeptide exert anxiogenic-like effect on behaviour of mice in the plus-maze test.

Authors:  Elaine C Gavioli; Giles A Rae; Girolamo Calo'; Remo Guerrini; Thereza C M De Lima
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

8.  Alterations of N/OFQ and NOP receptor gene expression in the substantia nigra and caudate putamen of MPP+ and 6-OHDA lesioned rats.

Authors:  Manuela Di Benedetto; Chiara Cavina; Claudio D'Addario; Giorgia Leoni; Sanzio Candeletti; Brian M Cox; Patrizia Romualdi
Journal:  Neuropharmacology       Date:  2009-03       Impact factor: 5.250

9.  Intraperitoneal co-administration of low dose urethane with xylazine and ketamine for extended duration of surgical anesthesia in rats.

Authors:  Arun H S Kumar; Anthony J P Clover
Journal:  Lab Anim Res       Date:  2015-12-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.